Abstract
Mesenchymal stem cells (MSCs) found in the amniotic fluid (AF) have potential applications in cellular therapy and regenerative medicine. Banking has been possible since 2007 in Europe and 2009 in the US, but limited to 2nd trimester fluid. Our thesis proposes that 3rd trimester MSC are similar in viability, multipotency and proliferation potential to the ‘younger’ stem cells.Also data is limited regarding the maintenance of biological properties of the 3rd trimester stem cells after cryopreservation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
